SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Authors
Keywords
SARS-CoV-2, Natural immunity, Vaccines, Vaccination, Reinfections, Hybrid immunity
Journal
ENVIRONMENTAL RESEARCH
Volume 209, Issue -, Pages 112911
Publisher
Elsevier BV
Online
2022-02-09
DOI
10.1016/j.envres.2022.112911
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections
- (2022) Laith J. Abu-Raddad et al. Nature Communications
- SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance — Los Angeles County, California, November 7, 2021–January 8, 2022
- (2022) Phoebe Danza et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Infection fatality rate of COVID-19 in community-dwelling elderly populations
- (2022) Cathrine Axfors et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months
- (2021) Aodhán Seán Breathnach et al. JOURNAL OF INFECTION
- Immunological characteristics govern the transition of COVID-19 to endemicity
- (2021) Jennie S. Lavine et al. SCIENCE
- Clinical and Laboratory Findings in Patients with Potential SARS-CoV-2 Reinfection, May–July 2020
- (2021) James T Lee et al. CLINICAL INFECTIOUS DISEASES
- SARS‐CoV‐2 re‐infection risk in Austria
- (2021) Stefan Pilz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Calling for benefit–risk evaluations of COVID-19 control measures
- (2021) Günter Kampf et al. LANCET
- Predictors of severe symptomatic laboratory-confirmed SARS-COV-2 reinfection
- (2021) Efrén Murillo-Zamora et al. PUBLIC HEALTH
- Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
- (2021) Raymond A. Harvey et al. JAMA Internal Medicine
- Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort Study
- (2021) Megan M Sheehan et al. CLINICAL INFECTIOUS DISEASES
- Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing
- (2021) Adnan I Qureshi et al. CLINICAL INFECTIOUS DISEASES
- Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines
- (2021) Joseph A. Lewnard et al. EPIDEMIOLOGY
- Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations
- (2021) John P. A. Ioannidis EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Correlates of protection from SARS-CoV-2 infection
- (2021) Florian Krammer LANCET
- Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
- (2021) Christian Holm Hansen et al. LANCET
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- (2021) Victoria Jane Hall et al. LANCET
- Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
- (2021) Cristina Menni et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
- (2021) Andrew G Letizia et al. Lancet Respiratory Medicine
- The risk of SARS-CoV-2 reinfection in Duhok city, Kurdistan Region of Iraq
- (2021) Nawfal R Hussein Mediterranean Journal of Hematology and Infectious Diseases
- Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials
- (2021) Qinglin Cheng et al. Aging-US
- Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk
- (2021) Efrén Murillo-Zamora et al. BMC INFECTIOUS DISEASES
- Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection
- (2021) Puya Dehgani-Mobaraki et al. CLINICAL IMMUNOLOGY
- Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients
- (2021) Jeff Slezak et al. CLINICAL MICROBIOLOGY AND INFECTION
- COVID‐19 Vaccination in Children and University Students
- (2021) John P.A. Ioannidis EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19
- (2021) Maddalena Peghin et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- ChAdOx1 nCoV-19 effectiveness during an unprecedented surge in SARS COV-2 infections
- (2021) Ruma Satwik et al. European Journal of Internal Medicine
- Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021
- (2021) Jefferson M. Jones et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies
- (2021) Aodhán Seán Breathnach et al. JOURNAL OF INFECTION
- Immunity to SARS‐CoV‐2 induced by infection or vaccination
- (2021) Xaquin Castro Dopico et al. JOURNAL OF INTERNAL MEDICINE
- Robust humoral and cellular immune responses and low risk for reinfection at least eight months following asymptomatic to mild COVID‐19
- (2021) Sebastian Havervall et al. JOURNAL OF INTERNAL MEDICINE
- Rate of reinfections after SARS-CoV-2 primary infection in the population of an Italian province: a cohort study
- (2021) M E Flacco et al. JOURNAL OF PUBLIC HEALTH
- Highly effective naturally acquired protection against COVID-19 persists for at least one year: A meta-analysis
- (2021) Marek Petráš Journal of the American Medical Directors Association
- SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
- (2021) Jackson S. Turner et al. NATURE
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Variants and Vaccines
- (2021) Philip R. Krause et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 Prevention and Control Measures in Workplace Settings: A Rapid Review and Meta-Analysis
- (2021) Carolyn Ingram et al. International Journal of Environmental Research and Public Health
- Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys
- (2021) Siyu Chen et al. PLoS Computational Biology
- Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy
- (2021) Josè Vitale et al. JAMA Internal Medicine
- Recurrent and persistent infection with SARS-CoV-2 – epidemiological data and case reports from Western Sweden, 2020
- (2021) Johan Ringlander et al. Infectious Diseases
- Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021
- (2021) Alyson M. Cavanaugh et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Benefit of COVID-19 vaccination accounting for potential risk compensation
- (2021) John P. A. Ioannidis npj Vaccines
- Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
- (2021) Carolina Garrido et al. JCI Insight
- Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
- (2021) Charles F. Schuler et al. Microbiology Spectrum
- Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study
- (2021) Hui Long et al. BMC INFECTIOUS DISEASES
- Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study
- (2021) Priscilla Kim et al. CLINICAL INFECTIOUS DISEASES
- A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
- (2021) N. Kojima et al. EVALUATION & THE HEALTH PROFESSIONS
- Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) – Kentucky, USA, 2020
- (2021) Kevin B. Spicer et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Winter of Omicron—The Evolving COVID-19 Pandemic
- (2021) Carlos del Rio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection
- (2021) Timothy A. Bates et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
- (2021) Laith J. Abu-Raddad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 vaccine strategies must focus on severe disease and global equity
- (2021) Peter B McIntyre et al. LANCET
- How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic
- (2021) Sudhvir Singh et al. LANCET
- Protective immunity after recovery from SARS-CoV-2 infection
- (2021) Noah Kojima et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 re-infection rate in Iranian COVID-19 cases within one-year follow-up
- (2021) Mostafa Salehi-Vaziri et al. MICROBIAL PATHOGENESIS
- Waning Immunity after the BNT162b2 Vaccine in Israel
- (2021) Yair Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection against Covid-19 by BNT162b2 Booster across Age Groups
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
- (2021) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- BNT162b2 Vaccine Booster and Mortality Due to Covid-19
- (2021) Ronen Arbel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
- (2021) Anil Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 Vaccine Effectiveness in New York State
- (2021) Eli S. Rosenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurrent SARS-CoV-2 infections and their potential risk to public health – a systematic review
- (2021) Seth Kofi Abrokwa et al. PLoS One
- How bad is Omicron? Some clues are emerging
- (2021) Kai Kupferschmidt et al. SCIENCE
- Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis
- (2021) Victoria Rotshild et al. Scientific Reports
- Covid-19: Early studies give hope omicron is milder than other variants
- (2021) Bryan Christie BMJ-British Medical Journal
- Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused
- (2021) Ivan Gentile et al. International Journal of Environmental Research and Public Health
- Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
- (2021) Laith J. Abu-Raddad et al. PLOS MEDICINE
- Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
- (2021) Gregory Milne et al. Lancet Respiratory Medicine
- Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis
- (2021) Nadim Sharif et al. Frontiers in Immunology
- SARS-CoV-2 Specific IgG Antibodies Persist Over a 12-Month Period in Oral Mucosal Fluid Collected From Previously Infected Individuals
- (2021) Prithivi Chellamuthu et al. Frontiers in Immunology
- Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection
- (2021) Margherita Rosati et al. Frontiers in Immunology
- Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021
- (2021) Catherine H. Bozio et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
- (2021) Shahad Saif Khandker et al. Vaccines
- Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
- (2021) Daniel Gussarow et al. Frontiers in Medicine
- Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis
- (2021) Qiuyue Ma et al. JAMA Network Open
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures
- (2020) John P. A. Ioannidis EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Vitamin D deficiency and COVID-19 pandemic
- (2020) Patrick Zemb et al. Journal of Global Antimicrobial Resistance
- SeroTracker: a global SARS-CoV-2 seroprevalence dashboard
- (2020) Rahul K Arora et al. LANCET INFECTIOUS DISEASES
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic
- (2020) John P. A. Ioannidis EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
- (2020) Laith J Abu-Raddad et al. CLINICAL INFECTIOUS DISEASES
- Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity
- (2020) Dafna Yahav et al. CLINICAL MICROBIOLOGY AND INFECTION
- Letter to the Editor Re: Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic
- (2020) Stefan Pilz EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection
- (2020) Aidan T. Hanrath et al. JOURNAL OF INFECTION
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now